Insider Transactions in Q2 2021 at Entasis Therapeutics Holdings Inc. (ETTX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2021
|
Innoviva, Inc. |
BUY
Open market or private purchase
|
Indirect |
6,268,975
+38.53%
|
$12,537,950
$2.0 P/Share
|
|
May 03
2021
|
Innoviva, Inc. |
BUY
Open market or private purchase
|
Indirect |
3,731,025
+50.0%
|
$7,462,050
$2.0 P/Share
|
|
Apr 01
2021
|
David C Hastings Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+50.0%
|
-
|
|
Apr 01
2021
|
David D. Meek Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+50.0%
|
-
|
|
Apr 01
2021
|
Heather A. Berger Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+50.0%
|
-
|
|
Apr 01
2021
|
Howard Mayer Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+50.0%
|
-
|